Rankings
▼
Calendar
HROW Q4 2021 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
Q4 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$20M
+38.3% YoY
Gross Profit
$15M
74.8% margin
Operating Income
-$2M
-8.7% margin
Net Income
-$7M
-36.7% margin
EPS (Diluted)
$-0.27
QoQ Revenue Growth
+7.9%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$28M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$98M
Total Liabilities
$87M
Stockholders' Equity
$11M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20M
$15M
+38.3%
Gross Profit
$15M
$11M
+41.8%
Operating Income
-$2M
$3M
-166.8%
Net Income
-$7M
$1M
-745.6%
Revenue Segments
Other Revenues
$1M
100%
← FY 2021
All Quarters
Q1 2022 →